# Developmental Funds

> **NIH NIH P30** · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · 2024 · $415,402

## Abstract

PROJECT SUMMARY: DEVELOPMENTAL FUNDS
Developmental Funds, derived from a variety of sources (CCSG, state, institutional, and philanthropy),
advance the mission, goals, and scientific activities of Sylvester Comprehensive Cancer Center (Sylvester)
through the support of innovative, collaborative, programmatic, and catchment area (CA) relevant science.
Guided by Sylvester’s Strategic Plan, the internally peer-reviewed Intramural Funding Program (IFP) utilizes
Developmental Funds to catalyze collaborative research and support promising ideas and investigators,
targeting specific areas of research priority, including transdisciplinary or translational science, community
outreach and engagement, and innovative clinical trials through a variety of pilot and non-pilot funding
mechanisms. Working closely with Sylvester Administration, the Deputy Director leads the IFP program to
execute a rigorous process for solicitation of funding opportunities, review of applications, awarding of funds,
and tracking of progress. IFP administration also oversees the American Cancer Society Institutional Research
Grant awards, leveraging these funds with additional institutional dollars, and the multi-center collaborative
Florida Academic Cancer Center Alliance pilot awards, conducted in partnership with Florida’s NCI-designated
cancer centers. Sylvester’s Scientific Steering and Executive Committees review and approve the priority
funding strategies each year, and over time, the IFP has offered 13 strategically-aligned funding mechanisms.
CCSG Developmental Funds specifically supported emerging scientific ideas through Transdisciplinary
Science Pilot awards and Translational Science Pilot Awards. $1.1M of CCSG Developmental Funds was
committed to support 12 projects, which have thus far resulted in $3.4M in extramural funding, yielding a return
on investment (ROI) of 3.1-fold. Combined CCSG and Sylvester Developmental Fund investments of $11.9M
into 111 research projects, during the reporting period, resulted in $58.7M in total awarded extramural research
awards (ROI = 4.9), 82 peer-reviewed publications, and 82 clinical trial accruals as of 5/31/23. During the
reporting period, $551,216 of CCSG Developmental Funds supported the development of three Shared
Resources (SRs), two of which are proposed as CCSG-supported SRs in this application. In the next funding
period, to support Sylvester’s CA-aligned research priorities, and its growth and maturation as an NCI-
designated cancer center, Developmental Funds will be used according to the following specific aims, to: 1)
Support transdisciplinary, translational and team science through pilot funding mechanisms that promote
innovative and collaborative research that impacts Sylvester’s CA and leads to extramural funding ($750K
CCSG investment), 2) Support innovative cancer research conducted by underrepresented minority
investigators through a dedicated early career pilot award program ($250K CCSG investment), and 3) Recru...

## Key facts

- **NIH application ID:** 10933322
- **Project number:** 2P30CA240139-06
- **Recipient organization:** UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- **Principal Investigator:** Stephen D. Nimer
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $415,402
- **Award type:** 2
- **Project period:** 2019-07-10 → 2029-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10933322

## Citation

> US National Institutes of Health, RePORTER application 10933322, Developmental Funds (2P30CA240139-06). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10933322. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*